Tivicay is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 6 kg.
It is prescribed in combination with other antiretroviral agents for the management of HIV-1 infection.
Tivicay is used to inhibit HIV-1 integrase, thereby preventing the integration of viral DNA into the host genome and reducing viral replication.
Dosage and administration
The recommended dosage of Tivicay for adults and pediatric patients weighing at least 30 kg is 50 mg once daily.
For pediatric patients weighing at least 6 kg to less than 30 kg, the dosage of Tivicay is determined based on body weight and should not exceed 50 mg once daily.
Tivicay can be taken with or without food.
For patients unable to swallow the tablet whole, Tivicay tablets can be crushed and mixed with a small amount of semi-solid food or liquid prior to administration.
It is important to take Tivicay consistently at the same time each day to maintain therapeutic levels in the body.
Patients should follow the dosage instructions provided by their healthcare provider and not adjust the dose without consulting them first.
Side effects
Common side effects of Tivicay may include headache, nausea, and diarrhea.
Some patients may experience rash, fatigue, or dizziness while taking Tivicay.
More serious side effects include allergic reactions, liver problems, and changes in mood or behavior.
Tivicay may also cause an increase in blood sugar levels in some patients.
Contact your doctor immediately if you experience any unusual side effects while taking Tivicay.
Precautions
Inform your healthcare provider if you have a history of liver problems or hepatitis.
Notify your healthcare provider if you are pregnant or planning to become pregnant.
Inform your healthcare provider if you are breastfeeding or planning to breastfeed.
Tell your healthcare provider about all other medications you are taking, including over-the-counter drugs and supplements.
Seek medical attention if you experience any signs of allergic reaction, such as rash, itching, or swelling of the face, lips, tongue, or throat.
Contact your healthcare provider if you develop any new or worsening symptoms while taking Tivicay.
Additional information
Brand Name:
Tivicay
Scientific Name:
Dolutegravir
Other Names:
Instgra
Strength(s):
50mg
Quantities Available:
30, 90
Formulation:
Tablet
All product content included on OnlineCanadianPharmacy.com is for information only. Please note that it is not a replacement for your individual professional medical care or advice. Always remember to speak with a qualified health professional before taking any prescription or non prescription medication.
At present, a power outage is affecting some of our services including our call center, email, and live chat. Our customer service is of the utmost importance and our team will tirelessly work until these services may resume. We apologize for any delays or hardships caused by this disruption in service, -- thank you for your patience.
Dolutegravir
